BMXMF (BioMerieux) Inventories, Raw Materials & Components: $437 Mil (As of Dec. 2025)


BMXMF BioMerieux SA BMXMF
67 GF Score
Price $82.78
GF Value $127.91
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is BioMerieux Inventories, Raw Materials & Components?

BioMerieux BMXMF 67 Inventories, Raw Materials & Components is $437 Mil as of Dec. 2025. GuruFocus rates BMXMF with a GF Score™ of 67/100 and a GF Value™ of $127.91 (Significantly Undervalued). The stock has 3 warning signs investors should review.

BioMerieux's inventories, raw materials & components for the quarter that ended in Dec. 2025 was $437 Mil.

BioMerieux's quarterly raw materials increased from Dec. 2024 ($416 Mil) to Jun. 2025 ($429 Mil) and increased from Jun. 2025 ($429 Mil) to Dec. 2025 ($437 Mil).

BioMerieux's annual raw materials increased from Dec. 2023 ($398 Mil) to Dec. 2024 ($416 Mil) and increased from Dec. 2024 ($416 Mil) to Dec. 2025 ($437 Mil).

BioMerieux Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for BioMerieux's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioMerieux Inventories, Raw Materials & Components Chart

BioMerieux Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 276.72 324.26 397.60 415.60 437.47

BioMerieux Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 397.60 407.10 415.60 429.41 437.47
BMXMF
67GF Score
BioMerieux SA BMXMF
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioMerieux Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $437 Mil mean?
BioMerieux (BMXMF) has a Inventories, Raw Materials & Components of $437 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on BioMerieux and its competitors.
Is BioMerieux's Inventories, Raw Materials & Components too high?
BioMerieux's current Inventories, Raw Materials & Components is $437 Mil. Overall, BioMerieux has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioMerieux's Inventories, Raw Materials & Components compare to TMO and DHR?
BioMerieux's Inventories, Raw Materials & Components of $437 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on BioMerieux and its competitors. BioMerieux's current Inventories, Raw Materials & Components is $437 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioMerieux stock overvalued right now?
Based on GuruFocus' analysis, BioMerieux (BMXMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $127.91, compared to a current price of $82.78 — trading 35.3% below its estimated fair value. The current Inventories, Raw Materials & Components is $437 Mil. BioMerieux's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For BioMerieux (BMXMF), the current Inventories, Raw Materials & Components is $437 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioMerieux (BMXMF) Overvalued in 2026?

Based on GuruFocus' analysis, BioMerieux stock appears to be undervalued. The current stock price of $82.78 is trading 35.3% below its estimated GF Value™ of $127.91. GuruFocus considers BioMerieux to be Significantly Undervalued.

Key valuation signals for BMXMF:

  • Inventories, Raw Materials & Components: $437 Mil
  • GF Value™: $127.91 vs. price of $82.78 (35.3% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BMXMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioMerieux Business Description

Address Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMérieux is headquartered in Marcy-l'Étoile, France.
67GF Score

Get the complete analysis for BMXMF

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.78
Price
$127.91
GF Value